More than 40 percent stop after just four weeks, according to research released by BCBSA and conducted by BHI
Eli Lilly has already sued four telehealth companies, including Fella Health and Henry Meds, for allegedly selling knockoff tirzepatide without evidence of safety or effectiveness after the FDA ruled that they had to stop
The safety of microdosing GLP-1 medications is not well-established, Stanford said
Dulaglutide: Moderate Weight Loss The pharmaceutical product Dulaglutide, marketed as Trulicity, delivers modest benefits for reducing weight
With a wide range of plausible effectiveness and costs of behavioral intervention, this alternative program was projected to generate substantial savings in net healthcare costs, with minimal loss of health-related quality of life
GLP-1 tablets may lead to more variable absorption patterns, particularly in the early weeks of therapy